Procter & Gamble Hygiene and Health Care Limited reported a 34% year-on-year decline in net profit for the quarter ended June 30, 2026, citing commodity cost fluctuations driven by geopolitical uncertainties. The Mumbai-based FMCG major posted a net profit of ₹126 crore (₹126.27 crore) for Q1FY26, down from ₹192.06 crore in the corresponding period of FY25. Revenue from operations contracted 5% to ₹891.46 crore, while EBITDA margin compressed sharply to 19.1% from 28.4%, reflecting significant operational pressure amidst strategic investments in innovation and advertising.

The Board of Directors approved the unaudited financial results at a meeting held on July 29, 2026. The results were prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) and reviewed by the Audit Committee. Statutory Auditors Kalyaniwalla & Mistry LLP issued a limited review report, confirming no material misstatement. The figures for the preceding quarter ended March 31, 2026, represent balancing figures between audited full-year data and published year-to-date figures.

Financial Performance Overview

The following table summarizes the key financial metrics for Q1FY26 against the corresponding period last year:

A detailed breakdown of income and expenditure items is presented below:

Expense Analysis and Strategic Investment

Total expenses rose 7.53% to ₹73,126 lakhs, outpacing the revenue decline and compressing margins significantly. Advertising and sales promotion expenses increased by 21% to ₹83.32 lakhs from ₹68.73 lakhs, indicating continued investment in brand visibility despite softer sales. Employee benefits expense grew 12% to ₹54.36 lakhs. Conversely, finance costs saw a reduction to ₹0.27 lakhs from ₹0.07 lakhs, while cost of raw materials consumed increased moderately to ₹200.24 lakhs.

Profit before tax fell 35.92% to ₹16,963 lakhs. Income tax expense was ₹43.36 lakhs, including current tax of ₹43.89 lakhs and a deferred tax credit of ₹0.53 lakhs. Earnings per share (basic and diluted) declined to ₹38.90 from ₹59.17 in the previous year's corresponding quarter.

What the Numbers Show

The sharp contraction in EBITDA margin—from 28.4% to 19.1% year-on-year—underscores the scale of operational challenges facing the company in Q1FY26. Kumar Venkatasubramanian, Managing Director, attributed the PAT impact to commodity cost fluctuations due to geopolitical uncertainties. The divergence between revenue decline and expense growth highlights significant operational leverage pressures. The 21% surge in advertising spend suggests management is prioritizing market share retention or new product penetration over immediate profitability, aligning with the stated strategy to position the company for long-term competitiveness. The absence of segment-wise disclosure, as Health Care and Hygiene products are aggregated into a single reportable segment, limits granular analysis of which product lines drove the volume or price mix changes.

Procter & Gamble Hygiene and Health Care Limited has fixed Wednesday, August 26, 2026, as the record date to determine shareholder eligibility for its 62nd Annual General Meeting (AGM) and dividend payment. The company announced that the AGM is scheduled to be held on Wednesday, September 2, 2026. Shareholders recorded in the register of members on the record date will be entitled to attend the meeting and receive the dividend, subject to approval at the AGM.

The dividend, if approved by the shareholders during the 62nd AGM, is expected to be paid to eligible members by September 30, 2026. This disbursement schedule provides a clear timeline for investors regarding the distribution of returns following the meeting. The announcement serves as an update to the schedule previously communicated to the stock exchanges.

Key Schedule for AGM and Dividend

The communication was formally submitted to The BSE Limited and The National Stock Exchange of India Limited to ensure the updated schedule is recorded on the exchanges. The company’s scrip codes are 500459 on the BSE and PGHH on the NSE.